Privia Health Group Posts Strong Earnings Results

The healthcare technology company exceeded analyst expectations for Q4 2025 revenue and earnings.

Published on Feb. 27, 2026

Privia Health Group (NASDAQ:PRVA), a physician enablement company, reported its fourth quarter 2025 financial results on Thursday. The company posted earnings per share of $0.25, surpassing the consensus estimate of $0.04. Privia also reported revenue of $541.17 million, higher than the expected $516.61 million. The strong performance was driven by continued growth in the company's clinically integrated network and technology platform that supports independent physicians and medical groups.

Why it matters

Privia Health Group's solid earnings demonstrate the company's ability to help healthcare providers navigate the shift towards value-based care models. As the industry continues to evolve, Privia's technology and services are becoming increasingly important for independent physicians and medical groups looking to optimize their financial performance and deliver coordinated, population health-focused care.

The details

Privia Health Group reported a 17.4% year-over-year increase in revenue, reaching $541.17 million in the fourth quarter. The company's net margin was 0.89% and it had a return on equity of 2.52%. Privia's strong financial results were driven by continued growth in its clinically integrated network and proprietary technology platform, which enable independent providers to better manage population health, deliver coordinated care, and optimize reimbursements.

  • Privia Health Group released its Q4 2025 earnings results on Thursday, February 27, 2026.

The players

Privia Health Group

A physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care through a clinically integrated network and proprietary technology platform.

Matthew Shawn Morris

A director at Privia Health Group who sold 13,647 shares of the company's stock in December 2025.

David Mountcastle

The Chief Financial Officer of Privia Health Group who sold 23,887 shares of the company's stock in December 2025.

Got photos? Submit your photos here. ›

The takeaway

Privia Health Group's strong financial performance underscores the growing demand for its technology-enabled services that help independent physicians and medical groups navigate the shift towards value-based care. As the healthcare industry continues to evolve, Privia's platform is becoming increasingly valuable for providers looking to optimize their financial and clinical outcomes.